GW

Gary Whale

Chief Technology Officer

Zura Bio Limited (Nasdaq: ZURA)

Henley-on-Thames, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Zura Bio Limited (Nasdaq: ZURA)
Industry
research
Employees
43.0
Seniority
C suite
Annual Revenue
1070000000.0

Technologies

Cloudflare DNS Mimecast Outlook Microsoft Office 365 Adobe Marketing Cloud Remote

Keywords

immunology inflammation biotechnology: biological products (no diagnostic substances) health care biotechnology research dual-pathway antibodies autoimmune diseases inflammatory diseases monoclonal antibodies il-17 baff il-7r tibulizumab crebankitug torudokimab clinical trials rheumatoid arthritis systemic sclerosis hidradenitis suppurativa therapeutic innovation patient care drug development biologics immunotherapy chronic inflammation b-cell signaling t-cell signaling physician collaboration regulatory approval biopharmaceutical drug efficacy patient commitment clinical indication biotech chronic disease management safety profile phase studies immune response modulation anti-inflammatory agents subcutaneous dosing immunological disorders biomedical research patient outcomes drug safety dual antagonism strategy transformative therapies disease-modifying drugs hnnovative solutions medical needs pathway targeting biotechnological advancements health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans